2016
DOI: 10.18203/2320-1770.ijrcog20160391
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the validity of risk malignancy index in clinically diagnosed ovarian masses and to compare it with the validity of individual constituent parameter of risk malignancy index

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 11 publications
(9 reference statements)
0
4
0
Order By: Relevance
“…22 Similar finding was seen in study in other studies. 23,24 Likewise, in this study, RMI 5 is better in comparison to its individual parameters for detection of malignancy. The diagnostic accuracy of RMI 5 is 94.44 which is similar to that of Doppler score 2 (94.7) while it is much higher than that of the rest of the parameters (CA-125: 72.2, Ultrasound score: 87.…”
Section: Resultsmentioning
confidence: 48%
“…22 Similar finding was seen in study in other studies. 23,24 Likewise, in this study, RMI 5 is better in comparison to its individual parameters for detection of malignancy. The diagnostic accuracy of RMI 5 is 94.44 which is similar to that of Doppler score 2 (94.7) while it is much higher than that of the rest of the parameters (CA-125: 72.2, Ultrasound score: 87.…”
Section: Resultsmentioning
confidence: 48%
“…As five-year survival in stage Ia is 80% we assume that this score will help in preoperative provisional diagnosis with early intervention. 5 The most common benign ovarian tumour was serous cystadenoma and malignant OC was serous cystadenocarcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…Preoperative detection is imperative from intervention point of view because in stage Ia (FIGO 2014) ovarian tumour the cure rate is more than 80%. 5 Moreover, it will prevent morbid surgeries and cost of therapy in benign ovarian tumour. The screening tests available are tumour markers (CA-125), Ultrasonography (USG), multimodality screening (CA-125 followed by USG), CT scan and MRI.…”
Section: Introductionmentioning
confidence: 99%
“…This signifies the need for a preoperative determination of the nature of an ovarian tumor before deciding on the appropriate plan of management. 5 The primary objective was to assess the efficacy of morphological index as a method to predict malignancy in sonographically confirmed ovarian tumors.…”
Section: Introductionmentioning
confidence: 99%